Politics Lilly, Novo bet on amylin obesity drugs after GLP-1s Finance News Oct 2, 2026 The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are… Read More...
Business Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial Finance News Sep 30, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of… Read More...
Business Novo obesity strategy as Eli Lilly extends lead Finance News Sep 27, 2026 The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,… Read More...
Politics Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug Finance News Sep 7, 2026 Blood sample for a lipoprotein(a) test.Md Babul Hosen | Istock | Getty ImagesNovartis' failure in a closely watched… Read More...
Politics Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill Finance News Aug 11, 2026 Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete… Read More...
Investing Eli Lilly Cancer Drug Wins FDA Breakthrough Therapy Status Finance News Aug 4, 2026 The US Food and Drug Administration (FDA) granted Breakthrough Therapy designation to Eli Lilly and Company's… Read More...
Politics Eli Lilly will file for approval of retatrutide obesity drug in 2027 Finance News Jul 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli… Read More...
Politics Novo Nordisk sues Eli Lilly over GLP-1 ads Finance News Jul 21, 2026 Photo illustration of a group of weight loss medications on a white background.Ucg | Universal Images Group | Getty… Read More...
Markets Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense Finance News Jul 21, 2026 The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about… Read More...
Finance Eli Lilly to Buy Psychedelics Firm AtaiBeckley for US$2.8 Billion Finance News Jul 18, 2026 Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is pushing further into the psychedelic drug market with a… Read More...